Pharmacy Cash Flow Management: 6 Proven Methods to Stop Running Out of Money
A pharmacy can show a profit on paper and still run out of cash. The gap between when you pay suppliers and when custome…
Pharmacy dead stock cost is the silent drain on profitability that most pharmacy owners underestimate. Dead stock includes expired medicines, damaged goods, recalled products, and slow-moving items that will not sell before they expire. For African pharmacies, dead stock typically represents 3 to 8 percent of total inventory value annually. On a pharmacy carrying 50 million shillings of stock, that is 1.5 to 4 million shillings destroyed every year without generating a single sale.
This guide shows you how to identify, measure, and systematically reduce your pharmacy dead stock cost using five practical methods. Each method addresses a different cause of dead stock and produces measurable results within one to three months of implementation.
Dead stock has four categories, each with different causes and different prevention strategies. Expired stock is medicine that has passed its use-by date and must be destroyed according to regulatory requirements. Damaged stock includes items with broken packaging, water damage, or temperature exposure that makes them unsaleable. Recalled products are items withdrawn by the manufacturer or the World Health Organisation due to safety concerns. Slow-moving stock is inventory that is approaching expiry with no realistic chance of selling in time.
Each category contributes to the total pharmacy dead stock cost differently. Expired stock is the largest component for most pharmacies, representing 60 to 70 percent of total write-offs. Damaged stock typically accounts for 15 to 20 percent, often caused by poor storage conditions or careless handling during receiving and shelving. Slow-moving stock is the most preventable category because it can be identified months before it becomes expired stock, giving the pharmacy time to act through discounting, returns, or transfers to branches where the product sells faster.
The true cost of dead stock goes beyond the purchase price. When a medicine expires, you lose the purchase cost, the storage space it occupied, the staff time spent receiving and shelving it, and the opportunity cost of the cash that was tied up in an item that generated no revenue. For controlled substances, there are additional disposal costs and regulatory documentation requirements that consume pharmacist time. Many pharmacies in East Africa also face environmental disposal fees for expired pharmaceuticals, adding another layer of cost that compounds the original purchasing loss and makes prevention even more valuable than the purchase price alone suggests.
Most pharmacies know they have dead stock but have never calculated the precise cost. Start by conducting a complete stock audit that identifies every item within 90 days of expiry, every item with visible damage, and every item that has not recorded a single sale in the past 180 days. Record the purchase price and quantity of each item on the list. Include items stored in back rooms and secondary storage areas, which are often forgotten during routine checks and are the most likely places for expired stock to accumulate unnoticed.
Calculate the total value at purchase cost, not at retail price. The purchase cost is what you actually lost, while the retail price is what you hoped to gain. Express the dead stock value as a percentage of your total inventory value and as a percentage of your annual cost of goods sold. Both figures tell you different things: the inventory percentage shows how much of your capital is trapped, while the COGS percentage shows how much dead stock is eroding your gross margin.
Set a quarterly review schedule to repeat this calculation. Tracking the trend matters more than any single number. A pharmacy that reduces dead stock from 6 percent to 4 percent of inventory value over two quarters is making measurable progress, even if 4 percent still feels high. The quarterly calculation creates accountability and makes the financial impact visible to everyone involved in purchasing and stock management decisions. Share the results with your purchasing team so they understand how their ordering decisions directly affect the bottom line and can adjust their habits accordingly.
The most effective prevention is catching slow-moving stock before it expires. Pharmacy management systems can generate alerts at 180, 90, 60, and 30 days before expiry, but alerts only work if someone acts on them. Assign a specific staff member to review the expiry report weekly and take action on every flagged item. Without clear ownership, expiry reports become background noise that everyone assumes someone else is handling.
At 180 days before expiry, review the item's sales velocity. If current sales rates will not clear the remaining stock before expiry, begin planning. Contact the supplier about return or exchange options. Check whether another branch or a partner pharmacy can use the stock. Identify whether a promotional discount would accelerate sales without destroying margin on the broader product category.
At 90 days, escalate unsold items. Reduce the price to clear remaining stock, offer bundle deals with faster-moving products, or contact the manufacturer directly about returns. At 30 days, any remaining stock should be quarantined from the dispensing shelf to prevent accidental sale of near-expired medicines. The quarantine triggers the disposal documentation process and ensures the write-off is recorded accurately in your financial records. Document each decision and its outcome so the pharmacy builds a reference of which strategies worked for which product categories, improving future responses to approaching expiry dates.
| Category | Typical Share of Write-offs | Primary Cause | Prevention Window | Recovery Potential |
|---|---|---|---|---|
| Expired stock | 60 to 70% | Over-ordering, poor rotation | 180 days before expiry | Supplier returns, discounting |
| Damaged goods | 15 to 20% | Storage, handling | At receiving | Insurance claims, supplier credit |
| Recalled products | 5 to 10% | Manufacturer issues | At recall notice | Manufacturer credit |
| Slow-moving items | 10 to 15% | Poor demand forecasting | After 90 days of low sales | Transfers, promotional pricing |
Many suppliers accept returns of near-expiry stock under specific conditions, but pharmacies rarely ask. Before placing your next order with each major supplier, negotiate a return policy. Common terms include returns accepted up to 90 days before expiry, credit note issued for the purchase price minus a restocking fee of 5 to 15 percent, and a minimum return quantity per item.
Document every return agreement in writing. A verbal promise from a sales representative is worthless when you need to return 200,000 shillings of near-expiry stock. The written agreement should specify the expiry window for eligible returns, the credit calculation method, the process for initiating a return, and the timeline for receiving the credit note. Keep these agreements accessible to whoever manages your purchasing so they can factor return options into ordering decisions.
Track the value of returns processed each quarter. This figure represents direct savings from your pharmacy dead stock cost that would otherwise be a total write-off. A pharmacy that recovers 40 percent of its near-expiry stock value through supplier returns has effectively reduced its dead stock cost by almost half without changing its purchasing patterns. Over time, the return data also reveals which suppliers offer the best terms and which products have the highest return rates, informing better purchasing decisions going forward and building stronger supplier relationships.
First-expiry-first-out (FEFO) dispensing ensures that the stock closest to expiry is dispensed first, reducing the chance of items expiring on the shelf. This principle is simple but requires consistent implementation across every staff member and every product in the pharmacy. Without enforcement, newer stock with longer shelf life gets dispensed first simply because it sits at the front of the shelf after delivery, and older stock quietly ages behind it until it is too late to sell.
During stock receiving, new deliveries must go behind existing stock on the shelf, not in front of it. This single practice prevents the most common cause of unnecessary expiry: newer stock sitting at the front gets dispensed while older stock at the back expires unnoticed. In pharmacies with deep shelves, use shelf dividers or markers to keep batches separated and visible. Train staff to check expiry dates when shelving and to flag any product where the existing shelf stock has less than 90 days remaining so the expiry protocol can begin immediately.
Pharmacy software that tracks batches and expiry dates can enforce FEFO automatically. When a pharmacist dispenses a product, the system selects the batch closest to expiry and records the specific batch dispensed. This removes the reliance on staff memory and shelf organisation, which are both unreliable in busy dispensing environments. Systems like Synapse flag when a pharmacist attempts to dispense a newer batch while an older batch is available, ensuring FEFO compliance without slowing down service.
Over-ordering is the root cause of most dead stock. Pharmacies that order based on intuition, supplier recommendations, or last month's purchase quantities inevitably buy too much of some items and too little of others. Data-driven demand forecasting reduces over-ordering by basing purchase quantities on actual sales history and seasonal patterns rather than guesswork or supplier pressure to meet volume targets.
Start with a simple calculation for each product: average monthly sales volume over the past six months, multiplied by the lead time in months from order to delivery, plus a safety stock buffer of 15 to 25 percent. This formula gives you the minimum order quantity needed to avoid stockouts without accumulating excess stock. For seasonal products like antimalarials, adjust the calculation using the same month's sales from the previous year rather than the trailing average, because a six-month average smooths out the very seasonal spikes you need to capture.
Review slow-moving products quarterly and make hard decisions. If a product has not sold in 90 days, question whether it belongs in your inventory at all. A medicine that sells two units per quarter ties up capital, occupies shelf space, and creates expiry risk for marginal revenue. Unless the product serves a critical clinical need with no substitute, consider removing it from your standard order list and sourcing it on demand when requested. This approach requires longer lead times for those occasional orders but eliminates the carrying cost and expiry risk entirely for products that do not justify permanent shelf space.
Every dead stock write-off must appear in your cost of goods sold, not as an operating expense. This placement is important because it directly reduces your gross margin, which is where dead stock damage actually occurs. A pharmacy that records write-offs as miscellaneous expenses understates its true COGS and overstates its gross margin, hiding the problem from financial analysis.
Create a specific line item in your monthly financial statement for stock write-offs, broken into the four categories: expired, damaged, recalled, and slow-moving disposals. This granularity reveals which type of dead stock is growing and where prevention efforts should focus. A pharmacy whose damaged stock write-offs are increasing has a storage or handling problem. A pharmacy whose expired stock write-offs are rising has a purchasing or rotation problem. The financial data points directly to the operational cause.
For a complete guide to managing your pharmacy's finances, see our pharmacy financial management guide. For guidance on accurate profit tracking, read our guide on pharmacy profit and loss tracking. For help managing overall inventory effectively, see our pharmacy inventory management guide.
Most African pharmacies lose 3 to 8 percent of total inventory value to dead stock annually. A well-managed pharmacy should target under 3 percent through proactive expiry management, supplier returns, and demand-based ordering.
Record expired stock as a write-off in your cost of goods sold, not as an operating expense. This correctly reduces your gross margin and makes the financial impact of dead stock visible in your monthly profit and loss statement.
Many suppliers accept returns of stock within 90 days of expiry, often issuing credit notes minus a restocking fee. Negotiate return terms in writing with each supplier before you need them. Not all products qualify, so check each agreement.
Start reviewing at 180 days before expiry when options like supplier returns, transfers to other branches, and promotional pricing are still available. At 90 days, escalate with price reductions. At 30 days, quarantine remaining stock for disposal.
A pharmacy can show a profit on paper and still run out of cash. The gap between when you pay suppliers and when custome…
Credit sales keep institutional customers loyal but drain cash flow when controls are weak. Most pharmacies lack a writt…
Most pharmacy owners know their daily sales total but cannot say with confidence whether the business made money last mo…
Sign up, create your pharmacy and start adding your stock. It takes a few minutes and you are looking at your own numbers straight away.